Outcomes of liver transplantation with liver grafts from pediatric donors used in adult recipients
Authors:
- Kristopher P. CroomeKCKristopher P. Croome
- C. Burcin TanerCTC. Burcin Taner
- Mayo Clinic Collaborative in Transplant Research and OutcomesMOMayo Clinic Collaborative in Transplant Research and Outcomes
- 26 July 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 22 (8) , 1099-1106
Abstract
Although there is an agreement that liver grafts from pediatric donors (PDs) should ideally be used for pediatric patients, there remain situations when these grafts are turned down for pediatric recipients and are then offered to adult recipients. The present study aimed to investigate the outcomes of using these grafts for liver transplantation (LT) in adult patients. Data from all patients undergoing LT between 2002 and 2014 were obtained from the United Network for Organ Sharing Standard Analysis and Research file. Adult recipients undergoing LT were divided into 2 groups: those receiving a pediatric liver graft (pediatric‐to‐adult group) and those receiving a liver graft from adult donors (adult‐to‐adult group). A separate subgroup analysis comparing the PDs used for adult recipients and those used for pediatric recipients was also performed. Patient and graft survival were not significantly different between pediatric‐to‐adult and adult‐to‐adult groups (P = 0.08 andP = 0.21, respectively). Hepatic artery thrombosis as the cause for graft loss was higher in the pediatric‐to‐adult group (3.6%) than the adult‐to‐adult group (1.9%;P < 0.001). A subanalysis looking at the pediatric‐to‐adult group found that patients with a predicted graft‐to‐recipient weight ratio (GRWR) < 0.8 had a higher 90‐day graft loss rate than those with a GRWR ≥ 0.8 (39% versus 9%;P < 0.001). PDs used for adult recipients had a higher proportion of donors with elevated aspartate aminotransferase/alanine aminotransferase (20% vs. 12%;P < 0.001), elevated creatinine (11% vs. 4%;P < 0.001), donation after cardiac death donors (12% vs. 0.9%;P < 0.001), and were hepatitis B virus core positive (1% vs. 0.3%;P = 0.002) than PDs used for pediatric recipients. In conclusion, acceptable patient and graft survival can be achieved with the use of pediatric liver grafts in adult recipients, when these grafts have been determined to be inappropriate for usage in the pediatric population.Liver Transplantation 22 1099–1106 2016 AASLDKeywords
This publication has 20 references indexed in Scilit:
- A formula for determining the standard liver volume in children: A special reference for neonates and infantsPediatric Transplantation, 2011
- Major Challenges Limiting Liver Transplantation in the United StatesAmerican Journal of Transplantation, 2011
- Regulation of hepatic blood flow: The hepatic arterial buffer response revisitedWorld Journal of Gastroenterology, 2010
- Graft weight/recipient weight ratio: How well does it predict outcome after partial liver transplants?Liver Transplantation, 2009
- Vascular Complications of Orthotopic Liver Transplantation: Experience in More than 4,200 PatientsJournal of the American College of Surgeons, 2009
- Early Hepatic Artery Thrombosis after Liver Transplantation: A Systematic Review of the Incidence, Outcome and Risk FactorsAmerican Journal of Transplantation, 2009
- Pediatric Liver and Kidney Transplantation With Allografts From DCD Donors: A Review of UNOS DataTransplantation, 2006
- Safety and risk of using pediatric donor livers in adult liver transplantationLiver Transplantation, 2001
- Outcome of the use of pediatric donor livers in adult recipientsLiver Transplantation, 2001
- Simplified Calculation of Body-Surface AreaNew England Journal of Medicine, 1987